An international team of haematologists have developed a prognostic model that can identify diffuse large B-cell lymphoma patients who are most likely to benefit from an allogeneic transplant following a failed prior autologous haematopoietic cell transplant. Writing in the study published in the British Journal of Haematology the research team including Professor Mark Hertzberg from ...
Prognostic tool identifies relapsed DLBCL patients most likely to benefit from alloHCT
By Tony James
17 Mar 2016